APO Research
Talk to an analyst

APO RESEARCH · REPORT

Implantable Coronary Drug Eluting Stent

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Implantable Coronary Drug Eluting Stent Market Outlook and Growth Opportunities 2026

28 December 2025194 pages

Choose your research edition.

Industry ResearchImplantable Coronary Drug Eluting Stent Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Implantable Coronary Drug Eluting Stent Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Implantable Coronary Drug Eluting Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Implantable Coronary Drug Eluting Stent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Implantable Coronary Drug Eluting Stent Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Implantable Coronary Drug Eluting Stent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Implantable Coronary Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Implantable Coronary Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Implantable Coronary Drug Eluting Stent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Implantable Coronary Drug Eluting Stent market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Implantable Coronary Drug Eluting Stent market include Yinyi Biotech, Abbott, Microport Medical, SINOMED, Beijing Amsino Medical, Medtronic, Lepu Medical, Boston Scientific and Terumo, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Implantable Coronary Drug Eluting Stent market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Implantable Coronary Drug Eluting Stent and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Implantable Coronary Drug Eluting Stent sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Implantable Coronary Drug Eluting Stent market size, projected growth trends, production technologies, key applications, and end-use industries.

Implantable Coronary Drug Eluting Stent Segment by Company

Yinyi Biotech

Abbott

Microport Medical

SINOMED

Beijing Amsino Medical

Medtronic

Lepu Medical

Boston Scientific

Terumo

Drug-eluting Stent

Implantable Coronary Drug Eluting Stent Segment by Type

Rapamycin

Everolimus

Paclitaxel

Other

Implantable Coronary Drug Eluting Stent Segment by Application

Angina Pectoris

Myocardial Infarction

Others

Implantable Coronary Drug Eluting Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Implantable Coronary Drug Eluting Stent status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Implantable Coronary Drug Eluting Stent market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Implantable Coronary Drug Eluting Stent significant trends, drivers, influence factors in global and regions.

6. To analyze Implantable Coronary Drug Eluting Stent competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Implantable Coronary Drug Eluting Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Implantable Coronary Drug Eluting Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Implantable Coronary Drug Eluting Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Implantable Coronary Drug Eluting Stent market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Implantable Coronary Drug Eluting Stent industry.

Chapter 3: Detailed analysis of Implantable Coronary Drug Eluting Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Implantable Coronary Drug Eluting Stent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Implantable Coronary Drug Eluting Stent in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Implantable Coronary Drug Eluting Stent Industry Trends Table 2. Implantable Coronary Drug Eluting Stent Industry Drivers Table 3. Implantable Coronary Drug Eluting Stent Industry Opportunities and Challenges Table 4. Implantable Coronary Drug Eluting Stent Industry Restraints Table 5. Global Implantable Coronary Drug Eluting Stent Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Implantable Coronary Drug Eluting Stent Revenue Share by Company (2021-2026) Table 7. Global Implantable Coronary Drug Eluting Stent Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Company (2021-2026) Table 9. Global Implantable Coronary Drug Eluting Stent Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Implantable Coronary Drug Eluting Stent Company Ranking, (2024-2026) & (USD Million) Table 11. Global Implantable Coronary Drug Eluting Stent Key Company Manufacturing Base & Headquarters Table 12. Global Implantable Coronary Drug Eluting Stent Company, Product Type & Application Table 13. Global Implantable Coronary Drug Eluting Stent Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Implantable Coronary Drug Eluting Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rapamycin Table 18. Significant Companies of Everolimus Table 19. Significant Companies of Paclitaxel Table 20. Significant Companies of Other Table 21. Global Implantable Coronary Drug Eluting Stent Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Implantable Coronary Drug Eluting Stent Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Implantable Coronary Drug Eluting Stent Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Type (2021-2026) Table 25. Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Type (2027-2032) Table 26. Global Implantable Coronary Drug Eluting Stent Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Implantable Coronary Drug Eluting Stent Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Implantable Coronary Drug Eluting Stent Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Type (2021-2026) Table 30. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Angina Pectoris Table 32. Significant Companies of Myocardial Infarction Table 33. Significant Companies of Others Table 34. Global Implantable Coronary Drug Eluting Stent Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Implantable Coronary Drug Eluting Stent Sales Volume by Application (2021-2026) & (K Units) Table 36. Global Implantable Coronary Drug Eluting Stent Sales Volume by Application (2027-2032) & (K Units) Table 37. Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Application (2021-2026) Table 38. Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Application (2027-2032) Table 39. Global Implantable Coronary Drug Eluting Stent Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Implantable Coronary Drug Eluting Stent Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Implantable Coronary Drug Eluting Stent Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Application (2021-2026) Table 43. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Application (2027-2032) Table 44. Global Implantable Coronary Drug Eluting Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Implantable Coronary Drug Eluting Stent Sales by Region (2021-2026) & (K Units) Table 46. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Region (2021-2026) Table 47. Global Implantable Coronary Drug Eluting Stent Sales by Region (2027-2032) & (K Units) Table 48. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Region (2027-2032) Table 49. Global Implantable Coronary Drug Eluting Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Implantable Coronary Drug Eluting Stent Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Region (2021-2026) Table 52. Global Implantable Coronary Drug Eluting Stent Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Region (2027-2032) Table 54. Global Implantable Coronary Drug Eluting Stent Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Implantable Coronary Drug Eluting Stent Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Implantable Coronary Drug Eluting Stent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Global Implantable Coronary Drug Eluting Stent Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Implantable Coronary Drug Eluting Stent Sales by Country (2021-2026) & (K Units) Table 59. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Country (2021-2026) Table 60. Global Implantable Coronary Drug Eluting Stent Sales by Country (2027-2032) & (K Units) Table 61. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Country (2027-2032) Table 62. Global Implantable Coronary Drug Eluting Stent Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Implantable Coronary Drug Eluting Stent Sales Value Market Share by Country (2021-2026) Table 64. Global Implantable Coronary Drug Eluting Stent Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Implantable Coronary Drug Eluting Stent Sales Value Market Share by Country (2027-2032) Table 66. Yinyi Biotech Company Information Table 67. Yinyi Biotech Business Overview Table 68. Yinyi Biotech Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Yinyi Biotech Implantable Coronary Drug Eluting Stent Product Portfolio Table 70. Yinyi Biotech Recent Development Table 71. Abbott Company Information Table 72. Abbott Business Overview Table 73. Abbott Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Abbott Implantable Coronary Drug Eluting Stent Product Portfolio Table 75. Abbott Recent Development Table 76. Microport Medical Company Information Table 77. Microport Medical Business Overview Table 78. Microport Medical Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Microport Medical Implantable Coronary Drug Eluting Stent Product Portfolio Table 80. Microport Medical Recent Development Table 81. SINOMED Company Information Table 82. SINOMED Business Overview Table 83. SINOMED Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. SINOMED Implantable Coronary Drug Eluting Stent Product Portfolio Table 85. SINOMED Recent Development Table 86. Beijing Amsino Medical Company Information Table 87. Beijing Amsino Medical Business Overview Table 88. Beijing Amsino Medical Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Beijing Amsino Medical Implantable Coronary Drug Eluting Stent Product Portfolio Table 90. Beijing Amsino Medical Recent Development Table 91. Medtronic Company Information Table 92. Medtronic Business Overview Table 93. Medtronic Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Medtronic Implantable Coronary Drug Eluting Stent Product Portfolio Table 95. Medtronic Recent Development Table 96. Lepu Medical Company Information Table 97. Lepu Medical Business Overview Table 98. Lepu Medical Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Lepu Medical Implantable Coronary Drug Eluting Stent Product Portfolio Table 100. Lepu Medical Recent Development Table 101. Boston Scientific Company Information Table 102. Boston Scientific Business Overview Table 103. Boston Scientific Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Boston Scientific Implantable Coronary Drug Eluting Stent Product Portfolio Table 105. Boston Scientific Recent Development Table 106. Terumo Company Information Table 107. Terumo Business Overview Table 108. Terumo Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Terumo Implantable Coronary Drug Eluting Stent Product Portfolio Table 110. Terumo Recent Development Table 111. Drug-eluting Stent Company Information Table 112. Drug-eluting Stent Business Overview Table 113. Drug-eluting Stent Implantable Coronary Drug Eluting Stent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Drug-eluting Stent Implantable Coronary Drug Eluting Stent Product Portfolio Table 115. Drug-eluting Stent Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Implantable Coronary Drug Eluting Stent Distributors List Table 119. Implantable Coronary Drug Eluting Stent Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Implantable Coronary Drug Eluting Stent Product Image Figure 2. Global Implantable Coronary Drug Eluting Stent Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Implantable Coronary Drug Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 4. Global Implantable Coronary Drug Eluting Stent Sales (2021-2032) & (K Units) Figure 5. Global Implantable Coronary Drug Eluting Stent Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Implantable Coronary Drug Eluting Stent Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rapamycin Image Figure 10. Everolimus Image Figure 11. Paclitaxel Image Figure 12. Other Image Figure 13. Global Implantable Coronary Drug Eluting Stent Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Implantable Coronary Drug Eluting Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Type (2021-2032) Figure 16. Global Implantable Coronary Drug Eluting Stent Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Implantable Coronary Drug Eluting Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Type (2021-2032) Figure 19. Angina Pectoris Image Figure 20. Myocardial Infarction Image Figure 21. Others Image Figure 22. Global Implantable Coronary Drug Eluting Stent Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Implantable Coronary Drug Eluting Stent Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Application (2021-2032) Figure 25. Global Implantable Coronary Drug Eluting Stent Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Implantable Coronary Drug Eluting Stent Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Application (2021-2032) Figure 28. Global Implantable Coronary Drug Eluting Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 29. Global Implantable Coronary Drug Eluting Stent Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Implantable Coronary Drug Eluting Stent Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Implantable Coronary Drug Eluting Stent Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Implantable Coronary Drug Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 33. North America Implantable Coronary Drug Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Implantable Coronary Drug Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Implantable Coronary Drug Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Implantable Coronary Drug Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Implantable Coronary Drug Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Implantable Coronary Drug Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 39. South America Implantable Coronary Drug Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Implantable Coronary Drug Eluting Stent Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Implantable Coronary Drug Eluting Stent Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Implantable Coronary Drug Eluting Stent Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Implantable Coronary Drug Eluting Stent Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Rapamycin
  • Everolimus
  • Paclitaxel
  • Other
Applications
  • Angina Pectoris
  • Myocardial Infarction
  • Others
Companies covered
  • Yinyi Biotech
  • Abbott
  • Microport Medical
  • SINOMED
  • Beijing Amsino Medical
  • Medtronic
  • Lepu Medical
  • Boston Scientific
  • Terumo
  • Drug-eluting Stent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Implantable Coronary Drug Eluting Stent Sales Value (2021-2032)
  4. 1.2.2 Global Implantable Coronary Drug Eluting Stent Sales Volume (2021-2032)
  5. 1.2.3 Global Implantable Coronary Drug Eluting Stent Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Implantable Coronary Drug Eluting Stent Market Dynamics
  1. 2.1 Implantable Coronary Drug Eluting Stent Industry Trends
  2. 2.2 Implantable Coronary Drug Eluting Stent Industry Drivers
  3. 2.3 Implantable Coronary Drug Eluting Stent Industry Opportunities and Challenges
  4. 2.4 Implantable Coronary Drug Eluting Stent Industry Restraints
3 Implantable Coronary Drug Eluting Stent Market by Company
  1. 3.1 Global Implantable Coronary Drug Eluting Stent Company Revenue Ranking in 2025
  2. 3.2 Global Implantable Coronary Drug Eluting Stent Revenue by Company (2021-2026)
  3. 3.3 Global Implantable Coronary Drug Eluting Stent Sales Volume by Company (2021-2026)
  4. 3.4 Global Implantable Coronary Drug Eluting Stent Average Price by Company (2021-2026)
  5. 3.5 Global Implantable Coronary Drug Eluting Stent Company Ranking (2024-2026)
  6. 3.6 Global Implantable Coronary Drug Eluting Stent Company Manufacturing Base and Headquarters
  7. 3.7 Global Implantable Coronary Drug Eluting Stent Company Product Type and Application
  8. 3.8 Global Implantable Coronary Drug Eluting Stent Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Implantable Coronary Drug Eluting Stent Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Implantable Coronary Drug Eluting Stent Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Implantable Coronary Drug Eluting Stent Market by Type
  1. 4.1 Implantable Coronary Drug Eluting Stent Type Introduction
  2. 4.1.1 Rapamycin
  3. 4.1.2 Everolimus
  4. 4.1.3 Paclitaxel
  5. 4.1.4 Other
  6. 4.2 Global Implantable Coronary Drug Eluting Stent Sales Volume by Type
  7. 4.2.1 Global Implantable Coronary Drug Eluting Stent Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Implantable Coronary Drug Eluting Stent Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Implantable Coronary Drug Eluting Stent Sales Value by Type
  11. 4.3.1 Global Implantable Coronary Drug Eluting Stent Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Implantable Coronary Drug Eluting Stent Sales Value by Type (2021-2032)
  13. 4.3.3 Global Implantable Coronary Drug Eluting Stent Sales Value Share by Type (2021-2032)
5 Implantable Coronary Drug Eluting Stent Market by Application
  1. 5.1 Implantable Coronary Drug Eluting Stent Application Introduction
  2. 5.1.1 Angina Pectoris
  3. 5.1.2 Myocardial Infarction
  4. 5.1.3 Others
  5. 5.2 Global Implantable Coronary Drug Eluting Stent Sales Volume by Application
  6. 5.2.1 Global Implantable Coronary Drug Eluting Stent Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Implantable Coronary Drug Eluting Stent Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Implantable Coronary Drug Eluting Stent Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Implantable Coronary Drug Eluting Stent Sales Value by Application
  10. 5.3.1 Global Implantable Coronary Drug Eluting Stent Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Implantable Coronary Drug Eluting Stent Sales Value by Application (2021-2032)
  12. 5.3.3 Global Implantable Coronary Drug Eluting Stent Sales Value Share by Application (2021-2032)
6 Implantable Coronary Drug Eluting Stent Regional Sales and Value Analysis
  1. 6.1 Global Implantable Coronary Drug Eluting Stent Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Implantable Coronary Drug Eluting Stent Sales by Region (2021-2032)
  3. 6.2.1 Global Implantable Coronary Drug Eluting Stent Sales by Region: 2021-2026
  4. 6.2.2 Global Implantable Coronary Drug Eluting Stent Sales by Region (2027-2032)
  5. 6.3 Global Implantable Coronary Drug Eluting Stent Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Implantable Coronary Drug Eluting Stent Sales Value by Region (2021-2032)
  7. 6.4.1 Global Implantable Coronary Drug Eluting Stent Sales Value by Region: 2021-2026
  8. 6.4.2 Global Implantable Coronary Drug Eluting Stent Sales Value by Region (2027-2032)
  9. 6.5 Global Implantable Coronary Drug Eluting Stent Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Implantable Coronary Drug Eluting Stent Sales Value (2021-2032)
  12. 6.6.2 North America Implantable Coronary Drug Eluting Stent Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Implantable Coronary Drug Eluting Stent Sales Value (2021-2032)
  15. 6.7.2 Europe Implantable Coronary Drug Eluting Stent Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Implantable Coronary Drug Eluting Stent Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Implantable Coronary Drug Eluting Stent Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Implantable Coronary Drug Eluting Stent Sales Value (2021-2032)
  21. 6.9.2 South America Implantable Coronary Drug Eluting Stent Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Implantable Coronary Drug Eluting Stent Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Implantable Coronary Drug Eluting Stent Sales Value Share by Country, 2025 VS 2032
7 Implantable Coronary Drug Eluting Stent Country-level Sales and Value Analysis
  1. 7.1 Global Implantable Coronary Drug Eluting Stent Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Implantable Coronary Drug Eluting Stent Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Implantable Coronary Drug Eluting Stent Sales by Country (2021-2032)
  4. 7.3.1 Global Implantable Coronary Drug Eluting Stent Sales by Country (2021-2026)
  5. 7.3.2 Global Implantable Coronary Drug Eluting Stent Sales by Country (2027-2032)
  6. 7.4 Global Implantable Coronary Drug Eluting Stent Sales Value by Country (2021-2032)
  7. 7.4.1 Global Implantable Coronary Drug Eluting Stent Sales Value by Country (2021-2026)
  8. 7.4.2 Global Implantable Coronary Drug Eluting Stent Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Implantable Coronary Drug Eluting Stent Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Implantable Coronary Drug Eluting Stent Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Implantable Coronary Drug Eluting Stent Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yinyi Biotech
  2. 8.1.1 Yinyi Biotech Company Information
  3. 8.1.2 Yinyi Biotech Business Overview
  4. 8.1.3 Yinyi Biotech Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yinyi Biotech Implantable Coronary Drug Eluting Stent Product Portfolio
  6. 8.1.5 Yinyi Biotech Recent Developments
  7. 8.2 Abbott
  8. 8.2.1 Abbott Company Information
  9. 8.2.2 Abbott Business Overview
  10. 8.2.3 Abbott Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Abbott Implantable Coronary Drug Eluting Stent Product Portfolio
  12. 8.2.5 Abbott Recent Developments
  13. 8.3 Microport Medical
  14. 8.3.1 Microport Medical Company Information
  15. 8.3.2 Microport Medical Business Overview
  16. 8.3.3 Microport Medical Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Microport Medical Implantable Coronary Drug Eluting Stent Product Portfolio
  18. 8.3.5 Microport Medical Recent Developments
  19. 8.4 SINOMED
  20. 8.4.1 SINOMED Company Information
  21. 8.4.2 SINOMED Business Overview
  22. 8.4.3 SINOMED Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 SINOMED Implantable Coronary Drug Eluting Stent Product Portfolio
  24. 8.4.5 SINOMED Recent Developments
  25. 8.5 Beijing Amsino Medical
  26. 8.5.1 Beijing Amsino Medical Company Information
  27. 8.5.2 Beijing Amsino Medical Business Overview
  28. 8.5.3 Beijing Amsino Medical Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Beijing Amsino Medical Implantable Coronary Drug Eluting Stent Product Portfolio
  30. 8.5.5 Beijing Amsino Medical Recent Developments
  31. 8.6 Medtronic
  32. 8.6.1 Medtronic Company Information
  33. 8.6.2 Medtronic Business Overview
  34. 8.6.3 Medtronic Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Medtronic Implantable Coronary Drug Eluting Stent Product Portfolio
  36. 8.6.5 Medtronic Recent Developments
  37. 8.7 Lepu Medical
  38. 8.7.1 Lepu Medical Company Information
  39. 8.7.2 Lepu Medical Business Overview
  40. 8.7.3 Lepu Medical Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Lepu Medical Implantable Coronary Drug Eluting Stent Product Portfolio
  42. 8.7.5 Lepu Medical Recent Developments
  43. 8.8 Boston Scientific
  44. 8.8.1 Boston Scientific Company Information
  45. 8.8.2 Boston Scientific Business Overview
  46. 8.8.3 Boston Scientific Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Boston Scientific Implantable Coronary Drug Eluting Stent Product Portfolio
  48. 8.8.5 Boston Scientific Recent Developments
  49. 8.9 Terumo
  50. 8.9.1 Terumo Company Information
  51. 8.9.2 Terumo Business Overview
  52. 8.9.3 Terumo Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Terumo Implantable Coronary Drug Eluting Stent Product Portfolio
  54. 8.9.5 Terumo Recent Developments
  55. 8.10 Drug-eluting Stent
  56. 8.10.1 Drug-eluting Stent Company Information
  57. 8.10.2 Drug-eluting Stent Business Overview
  58. 8.10.3 Drug-eluting Stent Implantable Coronary Drug Eluting Stent Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Drug-eluting Stent Implantable Coronary Drug Eluting Stent Product Portfolio
  60. 8.10.5 Drug-eluting Stent Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Implantable Coronary Drug Eluting Stent Value Chain Analysis
  2. 9.1.1 Implantable Coronary Drug Eluting Stent Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Implantable Coronary Drug Eluting Stent Sales Mode & Process
  6. 9.2 Implantable Coronary Drug Eluting Stent Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Implantable Coronary Drug Eluting Stent Distributors
  9. 9.2.3 Implantable Coronary Drug Eluting Stent Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst